CLINICAL_TRIALS
withdrawal
· 2014-06-13
Clinical Trial Update: Dehydrated Human Amnion/Chorion Membrane (dHACM) for Recovery After Fractionated Ablative CO2 Laser Resurfacing of the Face [NA]
Summary
The MiMedx-sponsored clinical trial evaluating dehydrated human amnion/chorion membrane (dHACM) for recovery after fractionated ablative CO2 laser facial resurf…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: MiMedx Group, Inc. | Conditions: Scarring | NA | Status: WITHDRAWN